Clinical Trial Update: Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eltrombopag for chronic idiopathic thrombocytopenic purpura (ITP) completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Purpura Thrombocytopenic Idiopathic

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic | Phase 3 | Status: COMPLETED | Results posted: 2011-12-01